Blueprint Medicines Corp (DELISTED) (BPMC:DL)
129.46
0.00 (0.00%)
USD |
NASDAQ |
Jul 28, 16:00
Blueprint Medicines Total Liabilities (Quarterly): 853.47M for March 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| TG Therapeutics, Inc. | 417.81M |
| AVITA Medical, Inc. | 66.31M |
| Ardelyx, Inc. | 331.89M |
| Bristol Myers Squibb Co. | 78.29B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.196B |
| Shareholders Equity (Quarterly) | 342.13M |
| Debt to Equity Ratio | 1.133 |
| Current Ratio | 2.802 |
| Net Debt Paydown Yield | -0.52% |